Biotalys N.V (BTLS) | Stock Overview & Key Data
Biotalys N.V. | Mid-cap | Basic Materials
Biotalys N.V. | Mid-cap | Basic Materials
Biotalys N.V Performance Comparison
Stock Range
Today's Range
Low: €4.51
High: €4.92
on August 4, 2025
52 Week Range
Low: €2.51
High: €5.50
on April 7, 2025
on June 27, 2025
All-Time High: €7.98 on June 28, 2021
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Market Cap
€173.0M
EPS
-0.40
P/E Ratio (TTM)
N/A
Forward P/E
-11.12
P/B Ratio
6.04
PEG Ratio
-11.12
Div. Yield
N/A
ROE
-49.60%
Beta
0.964
Debt to Equity
17.56
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-217.37%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-23.00%
Return on Equity (TTM)
-49.60%
EBITDA
€-12.3M
Net Income (TTM)
€-13.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.08
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Biotalys N.V BTLS | 172.96M Mid-cap | -10.64% | -12.06% | 36.50% | 23.61% | 27.14% | 48.33% | -39.54% | -36.43% |
| Tessenderlo Group NV TESB | 1.62B Large-cap | -4.01% | 2.53% | 0.57% | 25.84% | 36.69% | 13.85% | -11.45% | 2.33% |
| Syneos Health SYENS | 7.25B Large-cap | -0.62% | 6.75% | 11.35% | -5.81% | 0.90% | -1.30% | -25.02% | -25.02% |
| Azelis Group NV AZE | 3.33B Large-cap | -9.52% | -2.51% | -3.37% | -32.91% | -31.48% | -22.02% | -38.79% | -52.82% |
| Solvay SA SOLB | 2.88B Large-cap | -7.41% | -5.63% | -18.93% | -5.17% | -11.18% | -10.89% | -68.02% | -60.16% |
| Titan Cement TITC | 2.67B Large-cap | -1.92% | -4.14% | -10.26% | -18.15% | -9.70% | 13.09% | 198.75% | 220.09% |
Ownership & Short Interest
Insider Ownership
47.84%
Institutional Ownership
22.05%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
32K
Average 90-Day Volume
47K
Biotalys N.V Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Biotalys N.V would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BTLS's 52-week high and low?
- In the last 52 weeks, Biotalys N.V reached a high of €5.50 (on June 27, 2025) and a low of €2.51 (on April 7, 2025).
- What is the market cap and P/E ratio for BTLS?
- Curious about Biotalys N.V's size and valuation? Its market capitalization stands at 172.96M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -11.12.
- Does BTLS pay dividends? If so, what's the yield?
- As for dividends, Biotalys N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Biotalys N.V's main competitors or similar companies to consider before investing?
When looking at Biotalys N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Tessenderlo Group NV
TESB1.62B Basic Materials Agricultural Inputs 13.85% -11.45% Syneos Health
SYENS7.25B Basic Materials Chemicals -1.30% -25.02% Azelis Group NV
AZE3.33B Basic Materials Specialty Chemicals -22.02% -38.79% Solvay SA
SOLB2.88B Basic Materials Chemicals -10.89% -68.02% Titan Cement
TITC2.67B Basic Materials Building Materials 13.09% 198.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Biotalys N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Biotalys N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -49.60%, the Debt to Equity ratio from the most recent quarter is 17.56, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BTLS?
- Looking at Biotalys N.V's growth, its revenue over the trailing twelve months (TTM) was €3M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of BTLS stock is held by insiders and institutions?
- Wondering who owns Biotalys N.V stock? Company insiders (like executives and directors) hold about 47.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 22.05%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.